Business & regional news

Orders will be processed immediately and shipments will start in the coming weeks

Results show that the use of InPen resulted in an increase in Time in Range among those in the studies ​

SCAI 2023 Scientific Sessions: Harmony™ Transcatheter Pulmonary Valve System Demonstrates Strong Clinical and Hemodynamic Outcomes at Two Years

Heart Rhythm 2023: Late-breaking analysis of the PULSED AF Trial reveals first of its kind significant, meaningful quality of life improvements and healthcare utilization benefits of the PulseSelect Pulsed Field Ablation System

12-month results reinforce versatility and durability for the treatment of paroxysmal and persistent AFib with the first-of-its-kind pulsed field ablation, radiofrequency, and high density mapping Sphere-9™ Catheter

MRI Care Pathway can increase flexibility and efficiency with new tools developed to streamline workflow

ACC.23/WCC Late-Breaking Clinical Trial: Evolut™ is only TAVR to show excellent outcomes in low-risk patients at 3 years

CRT 2023 Late-Breaking Data: CoreValve/Evolut™ platform demonstrates significantly lower bioprosthetic valve dysfunction compared to surgery at five years

Harmony™ Transcatheter Pulmonary Valve System is the first FDA-approved minimally invasive valve designed for the right side of the heart

ADVANCE Trial compares sac regression in the Medtronic Endurant™ II/IIs stent graft system and the Gore® Excluder®* AAA Device Family systems

London Valves 2022: Latest Transcatheter Aortic Valve Replacement Data for Treatment of Aortic Stenosis and Prosthetic Aortic Valve Degeneration

Late-breaking clinical presentations at VIVA show IN.PACT™ Admiral™ drug-coated PTA balloon catheter outperforms bare metal stents; maintains performance in real-world setting

Study data show clinically meaningful impact on quality of life and disease severity, even in the most complex patients

-- Nexpowder™* provides gastroenterologists improved visibility, controls upper gastrointestinal (GI) bleeding effectively and with ease^1,2,3 --

-- Nexpowder™* endoscopic hemostasis system showed a lower rebleeding rate and has nearly double the adhesive force of other hemostatic sprays^2,3 --

TCT 2022: Late-breaking data from Intrepid™ Pilot Study 3-year follow-up & 1-year follow-up from Transfemoral EFS study demonstrate promising valve performance Medtronic today announced new data...

TCT 2022: Pathological Findings Confirm Importance of Early Detection and Treatment of Thrombus on Valve Leaflets Medtronic today announced findings from its Pathological Study of Hypo-Attenuated...

TCT 2022: Medtronic Unveils Latest Transcatheter Aortic Valve Replacement Data in Late-Breaking Clinical Science and Presentations

Mid-term results of Optimize PRO clinical study reinforces benefits of predictability and control using cusp overlap technique

EXPAND TAVR II Pivotal Trial evaluating the Evolut™ TAVR platform in a new patient population

Medtronic, the global leader in medical technology, today announced new randomized controlled data demonstrating the sustained and superior performance of IN.PACT AV drug coated balloon (DCB)...

ACC.22: Late-breaking data show CoreValve™ and Evolut™ is the only platform to out-perform surgery in valve durability at five years